Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats. 2018

Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
Program of Laborant and Veterinary Health, N.D. Göle Vocational High school, Ardahan University, Ardahan, Turkey. Electronic address: yahyaaltinkaynak@ardahan.edu.tr.

OBJECTIVE L-theanine is the unique amino acid found in tea plants, has antioxidant and antiinflammatory activities, and functions in mental concentration and sleep quality. In this study, it is aimed to investigate the effects of L-theanine on doxorubicin (DOX, a chemotherapeutic agent) induced nephrotoxicity in rats, especially via GSH related enzymes. METHODS 32 male Sprague Dawley rats weighing 300-400 g were randomly assigned into 4 groups (n = 8) and the substances were given intraperitoneally to them: Control group (saline for 5 days); Theanine group (200 mg/kg/day theanine for 5 days); DOX group (single dose of 20 mg/kg DOX); DOX + Theanine group (20 mg/kg DOX at first day and 200 mg/kg/day theanine for 5 days). Kidney tissues were evaluated by histopathological analysis. Serum levels of blood urea nitrogen (BUN) and creatinine by spectrophotometrically; percentage of apoptosis indexes (AI%) in the tissues by TUNEL method; caspase-3 levels, reduced and oxidized glutathione (GSH and GSSG), gamma-glutamyltransferase 1 (GGT1), glutathione reductase (GR), glutathione peroxidase (GPx), and glutathione S-transferase (GST), nuclear factor kappa B p65 (NF-kB p65) by commercial kits; malondialdehyde (MDA) by spectrophotometrically were determined in plasma and kidney tissues. RESULTS According to DOX group, the DOX + Theanine group has much lower tissue and plasma GSSG, GGT1, NF-κB p65 levels and tissue AI%, whereas significantly higher GSH levels and GPx, GR, GST activities (P < 0.05). CONCLUSIONS It is suggested that L-theanine may have protective effects by enhancing effects on the antioxidant system of GSH and GSH-related enzymes against DOX-induced nephrotoxicity in rats. But this finding needs to be supported with further studies.

UI MeSH Term Description Entries
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
November 2017, Journal of biochemical and molecular toxicology,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
December 2021, Tissue & cell,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
August 2021, Saudi journal of biological sciences,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
January 2014, Nephron. Experimental nephrology,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
September 2005, Biological & pharmaceutical bulletin,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
January 1997, Journal of applied toxicology : JAT,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
December 2015, Scientific reports,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
January 2012, Journal of Asian natural products research,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
January 2003, Journal of applied toxicology : JAT,
Yahya Altınkaynak, and Birgül Kural, and Buket A Akcan, and Akın Bodur, and Serap Özer, and Esin Yuluğ, and Sevdegül Munğan, and Cansu Kaya, and Asım Örem
January 1999, Life sciences,
Copied contents to your clipboard!